|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Regulus Therapeutics Inc. (RGLS)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2017-07-25 Purchase |
2017-07-25 6:09 pm |
Regulus Therapeutics Inc. | RGLS | WRIGHT TIMOTHY MICHAEL Chief R & D Officer |
274,725 | $0.91 | $250,000 | 274,725 (Direct) |
View |
| 2017-07-25 Purchase |
2017-07-25 6:09 pm |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
274,725 | $0.91 | $250,000 | 624,625 (Indirect) |
View |
| 2017-07-25 Purchase |
2017-07-25 6:08 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
219,780 | $0.91 | $200,000 | 241,297 (Direct) |
View |
| 2017-07-25 Purchase |
2017-07-25 6:07 pm |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
54,945 | $0.91 | $50,000 | 59,415 (Direct) |
View |
| 2017-07-25 Purchase |
2017-07-25 6:06 pm |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
1,000,000 | $0.91 | $910,000 | 1,770,677 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-06-01 Option Award |
2018-06-05 4:32 pm |
N/A 2028-05-31 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
55,000 | $0.73 | 55,000 (Direct) |
View |
| 2018-06-01 Option Award |
2018-06-05 4:31 pm |
N/A 2028-05-31 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
55,000 | $0.73 | 55,000 (Direct) |
View |
| 2018-06-01 Option Award |
2018-06-05 4:30 pm |
N/A 2028-05-31 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
55,000 | $0.73 | 55,000 (Indirect) |
View |
| 2018-06-01 Option Award |
2018-06-05 4:29 pm |
N/A 2028-05-31 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
55,000 | $0.73 | 55,000 (Direct) |
View |
| 2018-06-01 Option Award |
2018-06-05 4:29 pm |
N/A 2028-05-31 |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
55,000 | $0.73 | 55,000 (Direct) |
View |
| 2018-06-01 Option Award |
2018-06-05 4:28 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
7,695 | $0.74 | 55,000 (Direct) |
View |
| 2018-06-01 Option Award |
2018-06-05 4:28 pm |
N/A 2028-05-31 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
55,000 | $0.73 | 55,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:45 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | WRIGHT TIMOTHY MICHAEL Chief R & D Officer |
350,000 | $0.71 | 350,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:44 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
75,000 | $0.71 | 75,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:43 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
75,000 | $0.71 | 75,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:42 pm |
N/A 2028-05-17 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
75,000 | $0.71 | 75,000 (Indirect) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:41 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
75,000 | $0.71 | 75,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:40 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
725,000 | $0.71 | 725,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:39 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | Deeg Mark Albert Chief Medical Officer |
100,000 | $0.71 | 100,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:38 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
37,500 | $0.71 | 37,500 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:37 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
250,000 | $0.71 | 250,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:36 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
75,000 | $0.71 | 75,000 (Direct) |
View |
| 2018-04-14 Option Award |
2018-04-17 4:36 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
60,234 | $0.64 | 110,000 (Direct) |
View |
| 2018-04-14 Option Award |
2018-04-17 4:36 pm |
N/A 2028-04-13 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
110,000 | $0.64 | 110,000 (Direct) |
View |
| 2018-01-05 Option Award |
2018-01-05 6:59 pm |
N/A 2028-01-04 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
1,000,000 | $1.24 | 1,000,000 (Direct) |
View |
| 2018-01-05 Option Award |
2018-01-05 6:58 pm |
N/A 2028-01-04 |
Regulus Therapeutics Inc. | RGLS | WRIGHT TIMOTHY MICHAEL Chief R & D Officer |
500,000 | $1.24 | 500,000 (Direct) |
View |
| 2018-01-05 Option Award |
2018-01-05 6:57 pm |
N/A 2028-01-04 |
Regulus Therapeutics Inc. | RGLS | Deeg Mark Albert Chief Medical Officer |
175,000 | $1.24 | 175,000 (Direct) |
View |
| 2018-01-05 Option Award |
2018-01-05 6:55 pm |
N/A 2028-01-04 |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
350,000 | $1.24 | 350,000 (Direct) |
View |
| 2017-12-04 Option Award |
2017-12-06 7:43 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
60,674 | $0.89 | 60,674 (Direct) |
View |
| 2017-12-04 Option Award |
2017-12-06 7:42 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | FOLETTA MARK G Director |
71,910 | $0.89 | 81,910 (Direct) |
View |
| 2017-12-04 Option Award |
2017-12-06 7:41 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
96,629 | $0.89 | 1,797,306 (Direct) |
View |
| 2017-12-04 Option Award |
2017-12-06 7:40 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
56,179 | $0.89 | 56,179 (Direct) |
View |
| 2017-12-04 Option Award |
2017-12-06 7:39 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
60,674 | $0.89 | 60,674 (Direct) |
View |
| 2017-12-04 Option Award |
2017-12-06 7:38 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
69,662 | $0.89 | 694,387 (Indirect) |
View |
| 2017-12-04 Option Award |
2017-12-05 09:31 am |
2017-12-04 2026-10-02 |
Regulus Therapeutics Inc. | RGLS | WRIGHT TIMOTHY MICHAEL Chief R & D Officer |
100,000 | $3.3 | 100,000 (Direct) |
View |
| 2017-06-22 Option Award |
2017-06-23 4:22 pm |
N/A 2017-06-21 |
Regulus Therapeutics Inc. | RGLS | Deeg Mark Albert Chief Medical Officer |
100,000 | $0.99 | 100,000 (Direct) |
View |
| 2017-06-01 Option Award |
2017-06-02 4:41 pm |
N/A 2027-05-31 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
30,000 | $1.45 | 30,000 (Direct) |
View |
| 2017-06-01 Option Award |
2017-06-02 4:41 pm |
N/A 2027-05-31 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
30,000 | $1.45 | 30,000 (Direct) |
View |
| 2017-06-01 Option Award |
2017-06-02 4:40 pm |
N/A 2027-05-31 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
30,000 | $1.45 | 30,000 (Direct) |
View |
| 2017-06-01 Option Award |
2017-06-02 4:39 pm |
N/A 2027-05-31 |
Regulus Therapeutics Inc. | RGLS | FOLETTA MARK G Director |
30,000 | $1.45 | 30,000 (Direct) |
View |
| 2017-06-01 Option Award |
2017-06-02 4:38 pm |
N/A 2027-05-31 |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
30,000 | $1.45 | 30,000 (Direct) |
View |
| 2017-06-01 Option Award |
2017-06-02 4:37 pm |
N/A 2027-05-31 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
60,000 | $1.45 | 60,000 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Sun, 17 Jun 2018 18:39:38 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |